Pre-hospital metoprolol administration in Killip-class I–II anterior ST-segment elevation acute myocardial infarction is safe and reduces infarct size and adverse events. Insights from the METOCARD-CNIC trial
Resuscitation(2014)
摘要
Objective: Pre-reperfusion administration of i.v. metoprolol has been shown to reduce infarct size in Killip-class I–II anterior ST-segment elevation myocardial infarction (STEMI) patients undergoing primary angioplasty (METOCARD-CNIC trial, Circulation 2013). The objective of the present study was to study the effects of i.v. metoprolol administration in the pre-hospital emergency care environment.
更多查看译文
关键词
acute myocardial infarction,myocardial infarction,infarction size,pre-hospital,killip-class,st-segment,metocard-cnic
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络